6340 Sequence Drive
San Diego, CA 92121
United States
858 200 0200
https://www.dexcom.com
Setor(es): Healthcare
Indústria: Medical Devices
Funcionários Integrais: 9.500
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Kevin Ronald Sayer | Executive Chairman, CEO & President | 2,22M | N/A | 1958 |
Mr. Jereme M. Sylvain | Executive VP, CFO & Chief Accounting Officer | 841,14k | N/A | 1980 |
Mr. Jacob Steven Leach | Executive VP & COO | 994,13k | N/A | 1978 |
Mr. Girish Naganathan | Executive VP & CTO | 423,92k | N/A | 1977 |
Mr. Michael Jon Brown | Executive VP & Chief Legal Officer | 954,46k | N/A | 1970 |
Mr. Shelly Ramasamy Selvaraj | Senior VP & Chief Information Officer | N/A | N/A | 1959 |
Mr. Sean Christensen | Director of Corporate Affairs & Head of Investor Relations | N/A | N/A | N/A |
Mr. Matthew Dolan | Executive Vice President of Strategy, Corporate Development & Dexcom Labs | N/A | N/A | 1981 |
Ms. Leverne Marsh | Executive Vice President of Marketing | N/A | N/A | N/A |
Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer | N/A | N/A | 1975 |
O QualityScore de governança da ISS da DexCom, Inc. a partir de 1 de março de 2024 é 5. As principais pontuações para Auditoria são: 1; Conselho: 9; Direitos de Acionistas: 6; Compensação: 2.